Raia Drogasil S.A. Profit Margin

Raia Drogasil S.A. (RADLY) currently reports a profit margin of 2.99% as of June 2026. That compares with 2.98% in the prior-year period — up 0.1% year over year. That is below the Healthcare sector average of 14.41%. Use the charts on this page to explore Raia Drogasil S.A.'s profit margin history and peer comparisons.

Raia Drogasil S.A.'s profit margin increased from 2.98% to 2.99% — a 0.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Raia Drogasil S.A.'s profit margin of 2.99% is lower than the Healthcare sector average of 14.41%. That is roughly 79.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Raia Drogasil S.A.'s current 2.99% should be judged against Healthcare norms (sector average: 14.41%) and against RADLY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 2.99%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.41%. From there, open related valuation or income-statement pages for Raia Drogasil S.A., and consider following RADLY for alerts when major investors trade the stock.